DHR · News · 20261022N

AI Clinical Monitoring Product

DANAHER CORP /DE/ · 2026-10-22 · Importance 38 · Surprise 60

Danaher subsidiary Masimo received FDA clearance for AI-enabled atrial fibrillation detection in its Radius VSM wearable monitor. The feature uses artificial intelligence to identify potential AFib episodes through Masimo’s hospital-grade wireless device. It is intended for acute-care settings and expands Danaher’s digital monitoring and diagnostics technology portfolio.

Key facts

• The approved AI atrial fibrillation detection feature for Masimo's Radius VSM is intended for use in acute care settings source